AnalystsSean McCutcheonSean McCutcheon's Stock Forecasts
AnalystsSean McCutcheon
Sectors:
Industries:
Analyst Ranking
Top 28%
#1481 out of 5256 analysts
Average Return
+30.28%
Win Rate
42%5 out of 12
Risk vs Reward
Poor
Good
Sean McCutcheon's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Revolution Medicines IncRVMD | +214.14% | $46.55 | $146.23 | 2025-09-11 - 2026-04-20 | Strong Buy |
Revolution Medicines IncRVMD | +170.30% | $54.10 | $146.23 | 2025-10-16 - 2026-04-20 | Strong Buy |
Compass Therapeutics IncCMPX | +109.88% | $2.58 | $5.42 | 2025-06-30 - 2026-04-20 | Buy |
Vir Biotechnology IncVIR | +96.28% | $5.65 | $11.09 | 2025-07-10 - 2026-04-20 | Buy |
Black Diamond Therapeutics IncBDTX | +22.98% | $2.48 | $3.05 | 2025-06-30 - 2026-04-20 | Buy |
Sean McCutcheon Analyst Color
Get additional color on Sean McCutcheon's coverage of popular stocks
Sean McCutcheon's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Bridgebio Oncology Therapeutics IncBBOT | 1 | Buy | $24.00 | +159.18% | Initiates Coverage On | 3 months ago |
Revolution Medicines IncRVMD | 2 | Strong Buy | $76.00 | -48.03% | Maintains | 6 months ago |
Vir Biotechnology IncVIR | 1 | Buy | $12.00 | +8.21% | Initiates Coverage On | 9 months ago |
Janux Therapeutics IncJANX | 1 | Buy | $65.00 | +309.58% | Initiates Coverage On | 9 months ago |
Compass Therapeutics IncCMPX | 1 | Buy | $9.00 | +66.20% | Reinstates | 10 months ago |
Black Diamond Therapeutics IncBDTX | 1 | Buy | $11.00 | +260.66% | Reinstates | 10 months ago |
Engene Therapeutics IncENGN | 1 | Buy | $23.00 | N/A | Initiates Coverage On | a year ago |
Xencor IncXNCR | 1 | Strong Buy | $40.00 | N/A | Maintains | 2 years ago |
Cytokinetics IncCYTK | 2 | Buy | $70.00 | N/A | Maintains | 2 years ago |
Legend Biotech CorpLEGN | 1 | Buy | $86.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.